Last $107.26 USD
Change Today +1.46 / 1.38%
Volume 573.3K
LH On Other Exchanges
Symbol
Exchange
Berlin
New York
As of 12:57 PM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by LABORATORY CRP OF AMER HLDGS (LH) in the last 6 months

Announced 12/5/14
Bode Technology Group, Inc
Merger/Acquisition

Laboratory Corp. of America Holdings (NYSE:LH) acquired Bode Technology Group, Inc. from SolutionPoint International, Inc. on December 5, 2014. As a result of the acquisition, Bode Technology will operate as a wholly-owned subsidiary of Laboratory Corp. of America Holdings. Oppenheimer & Co. Inc. acted as financial advisor to Bode Technology Group.


LH's price was unchanged after the transaction was announced on 12/5/14.
Investor / Buyer
Laboratory Corp. of America Holdings
Creditor / Lender
SolutionPoint International, Inc.
Financial Advisor
Oppenheimer & Co. Inc.
 
Announced 11/25/14
15.00M for Vivify Health Inc.
Private Placement

Vivify Health Inc. announce that it will receive $15 million in its series B round of funding on November 25, 2014. The transaction included participation from new investors Laboratory Corp. of America Holdings and Envision Healthcare Holdings, Inc. As part of the round, Laboratory Corp. of America will join the company's board of directors. On the same date, the company announced that it has closed the first tranche of the transaction.


LH's price was unchanged after the transaction was announced on 11/25/14.
Investor / Buyer
Envision Healthcare Holdings, Inc.
Laboratory Corp. of America Holdings
 
Announced 11/18/14
15.00M for Advanced Animal Diagnostics, Inc.
Private Placement

Advanced Animal Diagnostics, Inc. announced that it will receive $14,770,889 in a round of funding on November 18, 2014. The company will issue common stocks as securities in the transaction. The company will issue the securities pursuant to exemption provided under Regulation D. The round will include participation from 11 investors.


LH's price was unchanged after the transaction was announced on 11/18/14.
Investor / Buyer
Cultivian Sandbox Ventures, LP
Intersouth Partners
Kansas Bioscience Authority
Laboratory Corp. of America Holdings
Middleland Capital
Novartis Venture Funds
 
Announced 11/3/14
6.38B for Covance Inc.
Merger/Acquisition

Laboratory Corp. of America Holdings (NYSE:LH) entered into a definitive agreement to acquire Covance Inc. (NYSE:CVD) for $6 billion on November 2, 2014. Under the terms of agreement, Laboratory Corp. shall acquire all shares of Covance for $105.12 each. Covance common stock holders, restricted stock holders, restricted stock units, deferred stock units and option holders will receive $75.76 in cash and 0.2686 Laboratory Corp. shares for each Covance share they own. ...
Read More


LH's price was unchanged after the transaction was announced on 11/3/14.
Investor / Buyer
Laboratory Corp. of America Holdings
Financial Advisor
Goldman, Sachs & Co.
Legal Advisor
Covington & Burling LLP
Cravath, Swaine & Moore LLP
 
Announced 09/25/14
101.00M for LipoScience, Inc.
Merger/Acquisition

Laboratory Corp. of America Holdings (NYSE:LH) entered into a definitive merger agreement to acquire LipoScience, Inc. (NasdaqGM:LPDX) from Armistice Capital LLC, Camden Partners Holdings, LLC, Cannell Capital LLC, Deerfield Capital, L.P., Deerfield Management Company, L.P., Pappas Ventures, Western Technology Investment, Three Arch Capital, TAC Associates, Sightline Healthcare and others for $83.8 million in cash on September 24, 2014. Laboratory Corp. will pay $5.25 ...
Read More


LH's price was unchanged after the transaction was announced on 09/25/14.
Investor / Buyer
Laboratory Corp. of America Holdings
Creditor / Lender
Armistice Capital LLC
Camden Partners Holdings, LLC
Cannell Capital LLC
Deerfield Capital, L.P.
Deerfield Management Company, L.P.
Gardner Lewis Asset Management LP
GE Equity
INVESCO Private Capital
Oakwood Medical Investors
Pappas Ventures
Sightline Healthcare Fund III, LP
SightLine Healthcare Opportunity Fund, LLC
SightLine Healthcare Vintage Fund, L.P.
Sightline Partners LLC
TAC Associates
Three Arch Capital
Three Arch Partners
Western Technology Investment
Financial Advisor
Canaccord Genuity Inc.
Legal Advisor
Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P.
 
Announced 07/28/14
16.00M for Seventh Sense Biosystems, Inc.
Private Placement

Seventh Sense Biosystems, Inc. announced that it will receive $16,467,084 in funding on July 28, 2014. The company will issue common shares, convertible debt and an option, warrant or other right to acquire another security in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. As of August 8, 2014, the company has received $10,467,084 in its first tranche close from eight investors.


LH's price was unchanged after the transaction was announced on 07/28/14.
Investor / Buyer
Flagship Ventures
Laboratory Corp. of America Holdings
Novartis AG
Polaris Partners
Siemens Financial Services, Inc.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LH:US $107.26 USD +1.46

LH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Reference Laboratories Inc $30.77 USD +0.86
Genomic Health Inc $31.71 USD +0.40
Myriad Genetics Inc $36.38 USD -0.04
QIAGEN NV €19.32 EUR +0.068
Quest Diagnostics Inc $67.24 USD +0.90
View Industry Companies
 

Industry Analysis

LH

Industry Average

Valuation LH Industry Range
Price/Earnings 17.8x
Price/Sales 1.5x
Price/Book 3.2x
Price/Cash Flow 14.9x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORY CRP OF AMER HLDGS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.